Price
Financials
Standalone, Rs crore| Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.19 | 5.39 | 1.14 | 11.27 | 4.70 | 3.85 | -0.51 | 1.29 | 1.52 | 1.58 | 0.59 | 1.19 |
| Expenses | 5.18 | 11.74 | 1.72 | 7.11 | 4.88 | 4.83 | 2.47 | 1.85 | 2.90 | 1.24 | 15.38 | 6.72 |
| Operating Profit | -2.99 | -6.35 | -0.58 | 4.16 | -0.18 | -0.98 | -2.98 | -0.56 | -1.38 | 0.34 | -14.79 | -5.53 |
| OPM % | -136.53% | -117.81% | -50.88% | 36.91% | -3.83% | -25.45% | -43.41% | -90.79% | 21.52% | -2,506.78% | -464.71% | |
| Other Income | 0.59 | 0.58 | 0.22 | 0.69 | 0.62 | 0.23 | -0.24 | 0.00 | 0.06 | 2.31 | 0.82 | 0.00 |
| Interest | 1.02 | 2.46 | 0.59 | 1.23 | 1.15 | 3.04 | -0.06 | 1.73 | 2.27 | 2.11 | -4.97 | 0.29 |
| Depreciation | 1.89 | 1.88 | 0.31 | 1.80 | 1.84 | 1.80 | 1.75 | 1.74 | 1.76 | 1.76 | 1.71 | 1.73 |
| Profit before tax | -5.31 | -10.11 | -1.26 | 1.82 | -2.55 | -5.59 | -4.91 | -4.03 | -5.35 | -1.22 | -10.71 | -7.55 |
| Tax % | 3.01% | -3.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.71% | 6.36% | -46.72% | 5.51% | 0.00% |
| Net Profit | -5.47 | -9.72 | -1.26 | 1.82 | -2.55 | -5.58 | -4.90 | -4.26 | -5.69 | -0.65 | -11.30 | -7.54 |
| EPS in Rs | -1.82 | -3.24 | -0.42 | 0.61 | -0.85 | -1.86 | -1.63 | -1.42 | -1.90 | -0.22 | -3.77 | -2.51 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39 | 65 | 85 | 95 | 117 | 140 | 157 | 24 | 9 | 18 | 5 | 5 |
| Expenses | 29 | 47 | 62 | 73 | 89 | 116 | 141 | 39 | 23 | 18 | 21 | 26 |
| Operating Profit | 10 | 18 | 23 | 22 | 28 | 25 | 16 | -14 | -13 | 0 | -16 | -21 |
| OPM % | 25% | 27% | 26% | 23% | 24% | 18% | 10% | -59% | -141% | 0.2% | -350% | -438% |
| Other Income | 0 | 0 | 1 | 0 | 0 | -3 | 6 | 1 | 4 | 1 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 2 | 4 | 4 | 5 | 7 | 5 | 1 | -0 |
| Depreciation | 1 | 2 | 1 | 2 | 3 | 5 | 13 | 22 | 7 | 7 | 7 | 7 |
| Profit before tax | 8 | 16 | 22 | 20 | 23 | 13 | 5 | -40 | -23 | -11 | -21 | -25 |
| Tax % | 5% | 7% | 2% | -1% | 0% | -5% | 39% | -5% | -1% | 0% | 3% | |
| Net Profit | 8 | 15 | 22 | 21 | 23 | 13 | 3 | -38 | -23 | -11 | -22 | -25 |
| EPS in Rs | 5.92 | 9.41 | 12.16 | 11.45 | 12.71 | 5.27 | 1.03 | -12.61 | -7.68 | -3.74 | -7.30 | -8.40 |
| Dividend Payout % | 17% | 11% | 8% | 9% | 8% | 19% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -19% | -49% | -42% | -48% | ||
| Compounded Profit Growth | % | % | 12% | -46% | ||
| Stock Price CAGR | -20% | % | % | % | ||
| Return on Equity | 1% | -14% | -26% | -39% |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 14 | 16 | 18 | 18 | 18 | 25 | 30 | 30 | 30 | 30 | 30 |
| Reserves | 18 | 26 | 59 | 89 | 107 | 143 | 202 | 234 | 74 | 47 | 37 | 15 |
| Borrowings | 2 | 1 | 1 | 1 | 12 | 41 | 40 | 37 | 47 | 46 | 49 | 50 |
| Other Liabilities | 2 | 6 | 9 | 23 | 15 | 14 | 16 | 25 | 21 | 24 | 26 | 28 |
| Total Liabilities | 32 | 47 | 85 | 131 | 153 | 217 | 282 | 325 | 172 | 147 | 142 | 122 |
| Fixed Assets | 13 | 18 | 29 | 27 | 35 | 78 | 110 | 139 | 106 | 95 | 88 | 81 |
| CWIP | 0 | 0 | 6 | 11 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 4 | 0 | 0 | 0 | 0 | 6 | 3 | 3 | 3 |
| Other Assets | 19 | 28 | 50 | 89 | 96 | 138 | 173 | 187 | 60 | 49 | 50 | 37 |
| Total Assets | 32 | 47 | 85 | 131 | 153 | 217 | 282 | 325 | 172 | 147 | 142 | 122 |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2 | 1 | 10 | -2 | 10 | -13 | -15 | 14 | -10 | 5 | 2 | 0 |
| Cash from Investing Activity | -6 | -7 | -19 | -21 | -20 | -25 | -36 | -43 | 5 | 3 | 1 | -0 |
| Cash from Financing Activity | 2 | 5 | 22 | 10 | 9 | 39 | 51 | 28 | 4 | -7 | -3 | -0 |
| Net Cash Flow | -2 | -0 | 14 | -13 | -1 | 1 | 0 | -1 | -0 | -0 | 0 | -0 |
| Free Cash Flow | -4 | -5 | -7 | -19 | -10 | -38 | -51 | -29 | 1 | 7 | 1 | -0 |
| CFO/OP | 19% | 12% | 59% | -7% | 46% | -48% | -62% | 85% | 65% | -35% | 6,100% | 0% |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 69 | 66 | 182 | 180 | 199 | 218 | 342 | 249 | 145 | 101 | 512 |
| Inventory Days | 421 | 481 | 564 | 734 | 543 | 386 | 218 | 121 | 697 | 1,766 | 1,847 | 628 |
| Days Payable | 33 | 31 | 10 | 237 | 102 | 27 | 19 | 51 | 517 | 1,105 | 378 | 185 |
| Cash Conversion Cycle | 442 | 519 | 619 | 679 | 621 | 559 | 417 | 412 | 428 | 806 | 1,570 | 955 |
| Working Capital Days | 165 | 201 | 149 | 272 | 255 | 236 | 228 | 299 | -437 | -1,651 | -322 | -2,267 |
| ROCE % | 33% | 24% | 28% | 24% | 17% | 15% | 9% | 3% | -15% | -12% | -5% | -19% |
| Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% | 24.46% |
| FIIs | 19.57% | 19.81% | 19.81% | 19.81% | 19.81% | 19.81% | 19.81% | 19.81% | 19.81% | 19.57% | 19.57% | 19.57% |
| DIIs | 1.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 53.99% | 55.73% | 55.73% | 55.73% | 55.73% | 55.73% | 55.73% | 55.73% | 55.73% | 55.97% | 55.97% | 55.97% |
| No. of Shareholders | 11,368 | 11,384 | 10,993 | 10,752 | 10,050 | 9,871 | 9,740 | 9,628 | 9,606 | 9,483 | 9,320 | 9,221 |
Fundamentals
Market Cap₹ 9.93 Cr.
Current Price₹ 3.31
Book Value₹ 14.9
ROCE-19.2 %
ROE-39.3 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-48%
Compounded Profit Growth (TTM)-46%
Standalone figures.
Valuation
P/B, 3-year average0.61x
P/E, 5-year average87.24x
P/B, 5-year average0.77x
Profitability
Operating margin (excl. other income)-350.21%
Operating margin (incl. other income)-281.84%
EBITDA margin-372.34%
Pre-tax margin-508.81%
Net profit margin-515.98%
Net margin, latest quarter-633.61%
ROE-39.31%
ROCE-19.20%
ROA-16.61%
ROE, 3-year average-26.79%
ROCE, 3-year average-12.10%
ROA, 3-year average-12.94%
ROE, 5-year average-19.93%
ROCE, 5-year average-9.72%
ROA, 5-year average-10.60%
ROIC (approx.)-27.32%
Tax rate-2.77%
Other income / net worth7.15%
Growth
Sales growth (latest year)-74.59%
Sales CAGR, 3 years-42.31%
Sales CAGR, 5 years-49.35%
Sales growth QoQ101.69%
Sales growth YoY (latest quarter)-7.75%
Per share
EPS (TTM)Rs -8.39
EPS (latest year)Rs -7.30
EPS (latest quarter)Rs -2.51
EPS, 3-year averageRs -6.24
EPS, 5-year averageRs -6.06
Book value per shareRs 14.92
Sales per shareRs 1.63
Free cash flow per shareRs -0.00
Efficiency
Asset turnover0.04x
Fixed asset turnover0.06x
Inventory turnover0.61x
Inventory days597 days
Debtor days512 days
Debtors turnover0.71x
Creditor days185 days
Cash conversion cycle955 days
Working capital days-2267 days
Leverage
Total debtRs 50 Cr
Cash and bankRs 0 Cr
Net debtRs 50 Cr
Debt to equity1.11x
Owners' fund to total sources36.65%
Debt to assets40.81%
Cash flow
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Statement figures
Net sales (TTM)Rs 5 Cr
Net sales (latest year)Rs 5 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -16 Cr
Operating profit (latest quarter)Rs -6 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs -18 Cr
PBDT (TTM)Rs -18 Cr
Profit before tax (TTM)Rs -25 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs -25 Cr
Net profit (latest year)Rs -22 Cr
Net profit (latest quarter)Rs -8 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs -0 Cr
Cost of goods sold (latest year)Rs 16 Cr
Total expenditure (latest year)Rs 21 Cr
Total income (latest year)Rs 8 Cr
Share capitalRs 30 Cr
ReservesRs 15 Cr
Shareholders' fundsRs 45 Cr
Total assetsRs 122 Cr
Net blockRs 81 Cr
InvestmentsRs 3 Cr
ReceivablesRs 7 Cr
InventoryRs 26 Cr
Other liabilitiesRs 28 Cr
Shares outstanding (crore)3.00
Ownership
Promoter holding24.46% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.22 is the lowest in 3.7 years (median 0.50).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Not enough price history.
Red flags
F-score 1 of 6| explain | Receivables outrunning sales Receivables grew 29% vs sales -75% in 2019 |
| look | Inventory outrunning sales Inventory grew -36% vs sales -75% in 2019 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2019Sales ₹1 Cr -7.8% vs Jun 2018.
Net loss ₹8 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Anthem Biosciences Ltd | 48,996 | 82.6 | 30.4 % |
| Advanced Enzyme Technologies Ltd | 3,152 | 20.0 | 14.0 % |
| CCME Global Ltd | 208 | -2.92 % | |
| Vivo Bio Tech Ltd | 36 | 7.74 % | |
| Shree Ganesh Biotech India Ltd | 19 | 1.31 % | |
| Genomic Valley Biotech Ltd | 9 | 886 | 1.02 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Camson Bio Technologies Ltd?
Camson Bio Technologies Ltd (538858) has a market capitalisation of Rs 9.93 Cr. at the close.
What were Camson Bio Technologies Ltd's latest quarterly results?
In the Jun 2019 quarter, Camson Bio Technologies Ltd sales was Rs 1 Cr (-7.8% vs Jun 2018) with a net loss of Rs 8 Cr.